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The effects of large doses of r.-phenylalanine and of aspartame on seizure susceptibility and severity have been assessed in baboons 
Papiopapio from Senegal which show photosensitive epileptic responses similar to primary generalised epilepsy in man. L-Phenylala- 
nine, 50,150 or 450 m@kg, or aspartame, 300 or 1000 mg/kg, were administered orally. Peak plasma L-phenylalanine concentrations 
of approximately 2OOOpmolesll occurred l-4 h after the highest dose of L-phenylalanine or aspartame. The plasma L-phenylalanine to 
large neutral amino acid ratio increased approximately 30-fold at this time. Compared with water administration there were no 
changes in epileptic responses l-5 h after either treatment. In this primate model of epilepsy acute increases in plasma phenylalanine 
concentration are neither pro- nor anticonvulsant. 
INTRODUCTION 
It has been suggested that the consumption of 
high doses of the sweetener aspartame (L-aspartyl- 
L-phenyl~anine methyl ester) can precipitate sei- 
zures in susceptible subjectsz9. To date, however, 
no documented cases have been published. Never- 
theless the suggestion requires investigation be- 
cause of the potential importance of the problem 
in public health terms and because there are con- 
flicting data concerning a putative proconvulsant 
effect of aspartame or of its hydrolysis product L- 
phenylalanine in rodent models of epilepsy. 
Chronic administration of L-phenylalanine (Phe) 
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reportedly enhances reflexly induced seizure re- 
sponses in mouse strains which are susceptible to 
audiogenic convulsions26. Acutely aspartame, 
1000 mglkg, or ~-phenylalanine, 560 mglkg, have 
been reported to enhance the convulsant effect of 
pentylenetetrazol or flurothyl in normal micez2. A 
lack of effect of aspartame, 1000-2500 mg/kg, has 
however, been reported in kindled, electroshock 
and sound-induced seizures in rats’2,‘3b and in 
uentvlenetetrazol and electroshock seizures in 
Two effects of phenylalanine could be relevant 
to seizure susceptibility. Firstly, Phe can compete 
with tyrosine (Tyr) for uptake into the brain (by 
the large neutral amino acid carrier)3. Secondly, 
Phe can inhibit the enzyme tyrosine hydroxylase, 
which catalyses the rate-limiting step in the syn- 
thesis of norepinephrineio. Both these effects 
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would be expected to decrease the synthesis of 
catecholamines in the brain. 
Direct evidence for an effect of Phe on seizure 
threshold in primates is so far lacking. We have, 
therefore, studied the effect of the acute oral ad- 
ministration of L-phenylalanine or of aspartame on 
photically induced myoclonic responses and on 
plasma concentrations of large neutral amino acids 
in Pupio papio from the Casamance region of Sen- 
ega12@. This model is highly susceptible to manipu- 
lation of brain monoamines. Dopamine agonists in 
low doses (e.g., apomorphine) have a protective 
effect2*“‘. The myoclonic responses to photic stim- 
ulation are also blocked by the intraventricular ad- 
ministration of norepinephrine’. Chronic reser- 
pine administration (leading to non-selective de- 
pletion of cerebral monoamines~ facilitates myo- 
clonic responses in animals initially showing low 
responsivity’. Photicalty induced myoclonus in this 
primate model corresponds closely in its electro- 
physiology and pharmacological responsiveness to 
primary generalised epilepsy in man. Thus, the 
photosensitive baboon would appear to be an ap- 
propriate animal model for testing the effect of 
aspartame or ~-phenylalanine on seizure thresh- 
old. 
MATERIALS AND METHODS 
Adolescent baboons from the Casamance region 
of Senegal were individually caged and main- 
tained under constant environmental conditions, 
They were seated in primate chairs and tested for 
photically induced myoclonic responses as de- 
scribed by Meldrum et al. I’. Four highly photosen- 
sitive adolescent baboons (2 males, 2 females, 
weights 6-8 kg) were selected for the Phe study. 
Each animal received (in random order, at weekly 
intervals) 0, 50,150 or 450 mg of phenylala~ine/kg 
by gavage. Myoclonic responses to a standardised 
5 min period of photic stimulation, prior to and at 
hourly intervals after drug administration, were 
scored according to Meldrum et al.“. Animals 
were closely observed throughout the 6-7 h pe- 
riod in the chair. On one-third of the days on which 
animals were tested, blood samples (from a femo- 
ral venous catheter} were taken into heparinised 
tubes prior to and at 0.5,1,2, and 4 h after Phe ad- 
TABLE I 
Study of the acute effect of L-phenylalanine on myaclonic re- 
sponses in photosensitive baboons, Papio papio 
Myodonic responses graded O-4 as in Meidrum et al.17. Each 
value represents the mean score in 4 baboons tested at the time 
indicated prior to or after an administration of L-phenylalanine 
or vehicle. 
Oral dose Time Myoclonic response 
(mglkg~ fmin) 
. --__-_--~ “___~___ 
-60 4s 10s 165 22s 285 
0 3.75 3.0 2.5 2.25 2.0 2.25 
50 3.75 2.75 2.00 2.25 3.0 2.25 
150 3.75 2.75 2.5 1.75 2.0 2.0 
450 3.75 3.5 2.5 2.25 2.25 2.25 
.._. .._ - .~ ._.. -..“--_-.--.l- “...__._. -. . ““..“__. .--- 
ministration. Plasma amino acid concentrations 
were dete~ined by ion exchange chromatogra- 
phy (Hazelton Laboratories, Madison, WI>. De- 
proteinised samples were diluted with an internal 
standard and analysed on a Beckman 7300 amino 
acid analyzer with post-column derivatization, 
The ratios of the phenyl~anine and tyrosine con- 
centration to the sum of the other large neutral 
amino acids, LNAA (considering valine, methio- 
nine, isoleucine, leucine, tyrosine, phenyl~anine 
and tryptophan as the LNAA), were calculated 
for each time point. 
For the aspartame study 4 further baboons were 
selected (3 females, weights 4-5 kg, 1 male, 
weight 5 kg) with high (n = 1) or intermediate (n = 
3) photosensitivity (to facilitate the demonstration 
of minor proconvulsant effects). Each animal re- 
ceived, orally, tap water, aspartame 300 mglkg, or 
aspartame 1000 mg/kg on 3 occasions (random or- 
der replicated Latin squares design’), at weekly in- 
tervals over a 3 month period. In each baboon ve- 
nous blood samples were taken for plasma amino 
acid analysis (as in the Phe study) on 1 out of the 3 
occasions with a given treatment. On every occa- 
sion myoclonic responses were assessed prior to, 
and at hourly intervals after, aspartame adminis- 
tration. 
The decreases in myoclonic scores from baseline 
were averaged over time for each series of obser- 
vations on a baboon. These average decreases 
were ranked within blocks, with mid-ranks calcu- 
lOI 
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Fig. 1. Changes in plasma phenyi~a~ne concentration after 
oral dosing of Phe (m, 0; q , 50; l , 150; and 0,450 rn~g~ in 
Papio papio. Each value represents the mean of meas~ements 
in 2 baboons. 
lated for ties. Friedman’s9 procedure was used to 
test the null hypothesis of no dose effect against a 
non-specific alternative hypothesis. Page’s9 test, 
which is more sensitive against the alternative hy- 
pothesis of a monotonic trend in responses for in- 
creasing doses, was also calculated when a mono- 
tonic tread in average ranks was observed. For the 
L-phenylalanine experiment, the series of obser- 
vations were blocked by baboon for purposes of 
comparing responses to the 4 doses. For the aspar- 
tame experiment, each of the 3 doses was used 
once each day, so that the doses were compared 
within days in the computation of ranks. 
RESULTS 
L-Pherzylulanine 
Similar decreases in the severity of the myoclon- 
ic response to photic stimulation were observed 
over time after each treatment (Table I). Ranking 
of the decreases in seizure score showed that there 
was no significant difference in dosage effects 
(Friedman’s test, empirical significance level P = 
0.34). 
Peak plasma Phe concentrations of 60, 93, 561 
and 2155 pmoles/l were observed approximately 
120 min after administration of Phe, 0,50,150 and 
450 mg/kg, respectively (see Fig. 1). In contrast, 
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TABLE II 
The acute effect of aspartame on myoclonic responses in photo- 
sensitive baboons, Papio papio 
Myoclonic responses graded O-4 as in Meldrum et a1.17. Each 
value represents the mean score for 4 baboons on 3 occasions at 
the times indicated prior to and after oral administration of as- 
partame or tap water. 
Oral dose Time 
Cm&W ~rn~n} 
~yoclonic response 
-60 45 105 165 225 285 
0 1.83 1.16 1.0 0.58 0.66 0.83 
300 1.41 1.25 0.83 0.75 0.75 0.75 
loo0 1.5 0.66 0.66 0.66 0.58 0.58 
plasma tyrosine levels did not exceed 78 pmoles/l 
in any baboon throughout the 4 h sampling period 
(Fig. 2). Calculation of the plasma Phe:large neu- 
tral amino acid ratio (a predictor of the competi- 
tive uptake of phenyl~anine into brain) revealed a 
dose-related 2-, ll- and 34-fold increase compared 
to control (Fig. 3). Thus even at extremely high 
concentrations of plasma Phe, neither pro- nor an- 
ticonvulsant effects were observed in baboons. 
Aspartame 
In all 4 baboons the scores for the myoclonic re- 
sponses were decreased after admi~stration of tap 
water or aspartame (see Table II). Statistical anal- 
ysis revealed no effect of treatment (Friedman’s 
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Fig. 2. Changes in plasma tyrosine concentration after oral dos- 
ing of Phe (m, 0; Cl, 50; 0, 150; and 0, 450 mg/kg). 
Values are the means of measurements in 2 baboons. 
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Fig. 3. Changes in the ratio of Phe to the sum of the large neu- 
tral amino acids in the plasma of baboons after Phe n , 0; 
q ,50;0,150;and0,450mg/kg. 
Plasma amino acid measurements showed that 
control (tap water) animals had Phe levels around 
50-60 pmoles/l (see Fig. 4). Peak Phe concentra- 
tion after an aspartame dose of 1000 mg/kg (Fig. 4) 
was close to that observed after administration of 
Phe in a dose of 450 mg/kg (Fig. 1). In each of 
these cases, Phe concentrations were close to 2000 
ymolesll. However, the peak after Phe occurred at 
, I I I I ’ 
0 60 120 180 240 
Minutes After Dosing 
Fig. 4. Changes in plasma phenylalanine concentration after 
oral dosing of aspartame (0, 0; A, 300; and H, 1000 mg/kg) 
in Pupio pupio. Each value represents the mean of measure- 
ments in 4 baboons. Error bars represent the standard devia- 
tion 
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Fig. 5. Ratio of Phe to the sum of the large neutral amino acids 
in plasma after aspartame 0, 0; A, 300; and n , 1000 
mg/kg orally in 4 baboons. Error bars represent the standard 
deviation. 
about 60 min, whereas the peak after aspartame 
occurred at approximately 120 min. The effect of 
aspartame 300 mg/kg on plasma Phe content was 
similar to that of Phe 150 mg/kg, but with a lower 
peak value. Control plasma tyrosine values were 
in the range 33-44 pmolesll (Fig. 5). Plasma tyro- 
sine values were between 79 and 91 pmolesil, l-4 
h after an aspartame dose of 1000 mg/kg. In the 
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Fig. 6. Ratio of Phe to the sum of the large neutral amino acids 
in plasma after aspartame n , 0; 0, 300; and @, 1000 
mgikg orally in 4 baboons. 
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of the PhelLNAA was 0.14 (see Fig. 6). This 
rose to 3.83 at 2 h after aspartame 1000 mg/kg (see 
Fig. 6). The Tyr/LNAA fell from a pretreatment 
value of 0.095-0.033 at 4 h (data curves not 
shown). The PhefIlr rose from 1.39 (pretreat- 
ment) to 24.7 at 4 h (curves not shown). 
DISCUSSION 
This study shows no effect (either proconvulsant 
or anticonvulsant) of high acute oral doses of L- 
phenylalanine or aspartame in baboons with pho- 
tosensitive epilepsy. This contrasts with the known 
sensitivity of this animal model to manipulation of 
monoaminergic systems, including noradrenergic, 
dopaminergic and serotoninergic activity. It also 
contrasts with some, but not all, published reports 
concerning sound-induced and chemically induced 
seizures in rodents. The proconvulsant action re- 
ported in DBA/2 mice at 22 days of age followed 
the administration of Phe as 2% of the diet to the 
mother and weanling26. In mice, an acute oral dose 
of aspartame 1000-2000 mg/kg or an equimolar 
dose of phenylalanine reportedly has a proconvul- 
sant action, when administered 1 h prior to pentyl- 
enetetrazol or ~~othyl”. Jobe et all’, however, 
found no potentiation of the convulsant effect of 
pentylenetetrazol in fasted or fed mice 1 h after as- 
partame 1.500-2500 mg/kg. Nevins et al.21 similar- 
ly found no effect of aspart~e on electroshock or 
pentylenetetrazol seizure thresholds in mice. In 
rats, Garratini et al.* found a weak potentiation of 
pentylenetetrazol’s convulsant action 60 min after 
aspartame, 1000 mg/kg orally. However, thresh- 
old currents for electroshock were not altered by 
aspartame administration. A lack of effect of as- 
partame in rats has also been reported for the rate 
of kindlir$, electroshock seizure threshold25, su- 
pramaximal electroshock seizure severityI and 
sound-induced seizures”. 
The peripheral metabolism of the amino acids 
that are precursors for monoamine neurotransmit- 
tersis quantitatively different in rodents compared 
with primates. Central nervous system metabo- 
lism may also be different. In particular, an oral 
dose of phenylalanine in rats produces a very 
marked increase in plasma tyrosine concentration, 
probably because of the high activity of phenylala- 
nine hydroxylase in rat livers@. In man, oral doses 
of phenylalanine or aspartame produce changes in 
plasma amino acid concentrations essentially equiv- 
alent to those we have found in baboons. Thus, 
normal adults receiving aspartame 100 or 200 mg/ 
kg show peak plasma concentrations of phenyl- 
alanine of 202 or 487 pmolesll after 0.75-l 5 h23,24. 
Tyrosine concentrations show a small but more 
prolonged elevation (from control values around 
50 Ftmolesil to peak values of 80-90 pmoles/l). For 
rodents, some data are available about changes in 
brain content of monoamines (and their extracel- 
lular ~n~entration) following administration of 
high doses of phenylalanine or aspartame, but the 
details and interpretation remain obscure. In rats 
aspartame, 200 mg/kg, produced a marked eleva- 
tion of brain tyrosine and phenylalanine content, 
but had only small and inconsistent effects on nor- 
epinephrine and did not alter brain tryptophan or 
serotonin content31732. Garattini et al.* found no 
changes in rat brain content of dopamine, 5-hy- 
drox~r~tamine or norepineph~ne (or their me- 
tabolites) after aspartame 250 mg/kg orally. In 
mice aspartame, 130 or 650 mg/kg orally, in- 
creased norepinephrine content by 50% in the hy- 
pothalamus and by smaller amounts elsewhere in 
the brain4. The content of dopamine and of vari- 
ous catecholamine metabolites was also increased. 
These findings do not support the assumption that 
catecholamine synthesis would be impaired by a 
high plasma phenylalanine concentration. Prelimi- 
nary studies using intracerebral dialysis in rats re- 
ceiving phenylalanine intraperitoneally indicate 
an increased release of dopamine after Phe, 200 
mgfkg, but a decreased release after Phe, 1000 
mg/kg5. No data are available about effects of Phe 
or aspartame on cerebral monoamine content or 
release in primates. 
Reports of seizures in man follo~ng aspartame 
consumption principally concern the acute con- 
sumption of large volumes of beverages (often 
with low sodium content)29. There is a high proba- 
bility that such seizures are attributable to rapid 
rehydration and hyponatraemia, a situation long 
known to precipitate seizures in patients with epi- 
lepsy or a reduced seizure threshold associated 
with cerebral pathology14,%. Controlled laborato- 
ry studies designed to differentiate the effects of 
6 
water load and aspartame on seizure threshold in 
man have not been reported. The possible effect 
of chronic administration of Phe or aspartame has 
not been addressed in this study. The absence of 
epidemiological data showing an increase in the in- 
cidence of new cases of epilepsy subsequent to the 
introduction of aspartame as a sweetener suggests 
that this is either not a widespread phenomenon or 
that it is a non-existent event. It remains possible 
that neurochemically specific syndromes of epilep- 
sy might be affected by alterations in plasma Phe. 
The two human epileptic syndromes that are mod- 
ified by monoaminer~ic manipulation (i.e.. photo- 
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